Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director
Por um escritor misterioso
Descrição
Sherry Layton, Vetanco Scientific Director, will be awarded in the 12th International Conference on Emerging Infectious Diseases
PDF) Development and initial evaluation of a candidate Clostridium perfringens a toxin-based necrotic enteritis vaccine utilizing recombinant Salmonella as a vaccine vector
Vaccines Conference-2022, Global Conference on Vaccines Research and Development
Vetanco Kenya and Ghana exhibitions - Vetanco
New Trends in Vaccine Development
Sherry Layton - Chief Executive Officer - Vetanco USA
Frontiers Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept
Frontiers Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept
Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director
News - BV Science
PDF) Vectorial Competence of Larvae and Adults of Alphitobius diaperinus in the Transmission of Salmonella Enteritidis in Poultry
Vetanco Sherry Layton, Vetanco USA Inc. CSO, was invited to give a presentation at Vaccines 2020 - Vetanco
PDF) Evaluation of a subunit vaccine candidate (Biotech Vac Cox) against Eimeria spp. in broiler chickens
Vetanco Sherry Layton, closing keynote at the 3rd edition of the Animal Microbiome Congress Europe - Vetanco
Emerging Diseases 2021, Emerging Infectious Diseases Conferences in 2021, Infectious Disease Conferences 2021, Emerging Infectious Diseases Conferences 2021, Rare Diseases 2021 Conferences, Europe, USA
Vaccines Conference-2022, Global Conference on Vaccines Research and Development
de
por adulto (o preço varia de acordo com o tamanho do grupo)
